Rank | Gene Set | Z-score |
---|---|---|
1 | ribosomal small subunit assembly (GO:0000028) | 5.66146910 |
2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.87373271 |
3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.05761898 |
4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.05761898 |
5 | response to interferon-beta (GO:0035456) | 3.95534634 |
6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.81704319 |
7 | viral transcription (GO:0019083) | 3.65771236 |
8 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.62561174 |
9 | neutrophil activation involved in immune response (GO:0002283) | 3.55610910 |
10 | translational termination (GO:0006415) | 3.47240404 |
11 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.35833422 |
12 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.33700378 |
13 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.32914248 |
14 | DNA deamination (GO:0045006) | 3.29112716 |
15 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.28741490 |
16 | protein targeting to ER (GO:0045047) | 3.25141076 |
17 | cotranslational protein targeting to membrane (GO:0006613) | 3.24674774 |
18 | response to interferon-alpha (GO:0035455) | 3.23352582 |
19 | immunoglobulin mediated immune response (GO:0016064) | 3.21237192 |
20 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.15506168 |
21 | ribosomal small subunit biogenesis (GO:0042274) | 3.11449605 |
22 | protein localization to endoplasmic reticulum (GO:0070972) | 3.11061498 |
23 | response to peptidoglycan (GO:0032494) | 3.10516143 |
24 | deoxyribonucleotide catabolic process (GO:0009264) | 3.09639572 |
25 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.05850548 |
26 | mature B cell differentiation involved in immune response (GO:0002313) | 3.04127126 |
27 | deoxyribose phosphate catabolic process (GO:0046386) | 3.03843150 |
28 | response to type I interferon (GO:0034340) | 3.00674351 |
29 | cellular response to type I interferon (GO:0071357) | 2.99332931 |
30 | type I interferon signaling pathway (GO:0060337) | 2.99332931 |
31 | translational elongation (GO:0006414) | 2.96884242 |
32 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.93931899 |
33 | defense response to protozoan (GO:0042832) | 2.88012882 |
34 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.87565939 |
35 | cellular response to interferon-beta (GO:0035458) | 2.87235629 |
36 | response to protozoan (GO:0001562) | 2.84640279 |
37 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.81552566 |
38 | positive regulation of interferon-alpha production (GO:0032727) | 2.78528224 |
39 | reactive oxygen species biosynthetic process (GO:1903409) | 2.78190894 |
40 | negative regulation of B cell apoptotic process (GO:0002903) | 2.77165081 |
41 | regulation of mast cell degranulation (GO:0043304) | 2.76496547 |
42 | respiratory burst (GO:0045730) | 2.74021867 |
43 | viral life cycle (GO:0019058) | 2.73336269 |
44 | positive regulation of B cell differentiation (GO:0045579) | 2.72847987 |
45 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.71606865 |
46 | endosome to melanosome transport (GO:0035646) | 2.71349008 |
47 | endosome to pigment granule transport (GO:0043485) | 2.71349008 |
48 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.70526397 |
49 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.70083471 |
50 | regulation of growth of symbiont in host (GO:0044126) | 2.70083471 |
51 | negative regulation of growth of symbiont in host (GO:0044130) | 2.70083471 |
52 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.70083471 |
53 | negative regulation of viral genome replication (GO:0045071) | 2.69127586 |
54 | actin nucleation (GO:0045010) | 2.68555922 |
55 | platelet dense granule organization (GO:0060155) | 2.66599888 |
56 | purine nucleotide salvage (GO:0032261) | 2.65956039 |
57 | regulation of B cell apoptotic process (GO:0002902) | 2.63125120 |
58 | maturation of SSU-rRNA (GO:0030490) | 2.62781369 |
59 | regulation of interferon-alpha production (GO:0032647) | 2.61751902 |
60 | B cell mediated immunity (GO:0019724) | 2.60912225 |
61 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.60276458 |
62 | positive regulation of antigen processing and presentation (GO:0002579) | 2.59728798 |
63 | myeloid dendritic cell activation (GO:0001773) | 2.58941082 |
64 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.58525566 |
65 | cellular response to zinc ion (GO:0071294) | 2.58483402 |
66 | negative regulation of interleukin-12 production (GO:0032695) | 2.57506407 |
67 | definitive hemopoiesis (GO:0060216) | 2.57363924 |
68 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.57352515 |
69 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.56767045 |
70 | positive regulation of mast cell degranulation (GO:0043306) | 2.56767045 |
71 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.56748738 |
72 | myeloid cell activation involved in immune response (GO:0002275) | 2.56424893 |
73 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.54116574 |
74 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.52831775 |
75 | regulation of RIG-I signaling pathway (GO:0039535) | 2.50725013 |
76 | signal peptide processing (GO:0006465) | 2.50017806 |
77 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.48666942 |
78 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.48600321 |
79 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.47001535 |
80 | regulation of natural killer cell differentiation (GO:0032823) | 2.46733719 |
81 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.46691025 |
82 | polyketide metabolic process (GO:0030638) | 2.46188440 |
83 | doxorubicin metabolic process (GO:0044598) | 2.46188440 |
84 | daunorubicin metabolic process (GO:0044597) | 2.46188440 |
85 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.45269202 |
86 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.45040702 |
87 | cellular response to interferon-gamma (GO:0071346) | 2.44603874 |
88 | positive regulation of prostaglandin secretion (GO:0032308) | 2.43416177 |
89 | positive regulation of respiratory burst (GO:0060267) | 2.43347563 |
90 | neutrophil activation (GO:0042119) | 2.43016076 |
91 | cellular protein complex disassembly (GO:0043624) | 2.42644480 |
92 | positive thymic T cell selection (GO:0045059) | 2.41732204 |
93 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.40322544 |
94 | cellular extravasation (GO:0045123) | 2.40182992 |
95 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.39928077 |
96 | cellular response to exogenous dsRNA (GO:0071360) | 2.39221583 |
97 | regulation of superoxide anion generation (GO:0032928) | 2.38425446 |
98 | glycosphingolipid catabolic process (GO:0046479) | 2.37343561 |
99 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.37264823 |
100 | granulocyte activation (GO:0036230) | 2.36950823 |
101 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.36812861 |
102 | response to interferon-gamma (GO:0034341) | 2.36233237 |
103 | detection of other organism (GO:0098543) | 2.35912672 |
104 | regulation of leukocyte degranulation (GO:0043300) | 2.35568484 |
105 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.34575073 |
106 | positive regulation of mast cell activation (GO:0033005) | 2.34445200 |
107 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.32749532 |
108 | superoxide anion generation (GO:0042554) | 2.32151607 |
109 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.31587740 |
110 | positive regulation of lymphocyte migration (GO:2000403) | 2.31433500 |
111 | translational initiation (GO:0006413) | 2.31310670 |
112 | toxin transport (GO:1901998) | 2.31102947 |
113 | regulation of mast cell activation (GO:0033003) | 2.30736832 |
114 | surfactant homeostasis (GO:0043129) | 2.29695656 |
115 | deoxyribose phosphate metabolic process (GO:0019692) | 2.29587092 |
116 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.29066138 |
117 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.28794940 |
118 | positive regulation of T cell migration (GO:2000406) | 2.28723468 |
119 | mast cell activation (GO:0045576) | 2.28276941 |
120 | regulation of antigen processing and presentation (GO:0002577) | 2.28119670 |
121 | amino sugar catabolic process (GO:0046348) | 2.27415481 |
122 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.26467455 |
123 | regulation of chemokine biosynthetic process (GO:0045073) | 2.26128198 |
124 | myeloid dendritic cell differentiation (GO:0043011) | 2.26020352 |
125 | lipoxygenase pathway (GO:0019372) | 2.25854870 |
126 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.25521179 |
127 | pinocytosis (GO:0006907) | 2.25450466 |
128 | regulation of T cell migration (GO:2000404) | 2.25207683 |
129 | cytidine metabolic process (GO:0046087) | 2.24976105 |
130 | cytidine catabolic process (GO:0006216) | 2.24976105 |
131 | cytidine deamination (GO:0009972) | 2.24976105 |
132 | regulation of hypersensitivity (GO:0002883) | 2.24780957 |
133 | nucleotide salvage (GO:0043173) | 2.24257772 |
134 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.24196623 |
135 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.24129892 |
136 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.24073873 |
137 | positive regulation of interferon-beta production (GO:0032728) | 2.22629714 |
138 | positive regulation of neutrophil migration (GO:1902624) | 2.22543039 |
139 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.22543039 |
140 | glycolipid catabolic process (GO:0019377) | 2.22299152 |
141 | detection of bacterium (GO:0016045) | 2.21585220 |
142 | histamine secretion (GO:0001821) | 2.20208416 |
143 | valine metabolic process (GO:0006573) | 2.19170896 |
144 | regulation of B cell differentiation (GO:0045577) | 2.18870063 |
145 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.17131189 |
146 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.16885921 |
147 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.15861842 |
148 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.15861842 |
149 | modulation by symbiont of host immune response (GO:0052553) | 2.15861842 |
150 | positive regulation by symbiont of host defense response (GO:0052509) | 2.15861842 |
151 | modulation by symbiont of host defense response (GO:0052031) | 2.15861842 |
152 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.15861842 |
153 | NIK/NF-kappaB signaling (GO:0038061) | 2.14081282 |
154 | regulation of gamma-delta T cell activation (GO:0046643) | 2.13196998 |
155 | response to muramyl dipeptide (GO:0032495) | 2.13047207 |
156 | xenobiotic catabolic process (GO:0042178) | 2.12246278 |
157 | detection of external biotic stimulus (GO:0098581) | 2.12067707 |
158 | response to thyroid hormone (GO:0097066) | 2.11225414 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.67438219 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.52019823 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.31938851 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.25560064 |
5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.94913426 |
6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.68066817 |
7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.67885597 |
8 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.41881500 |
9 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.39833670 |
10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.39687785 |
11 | GATA1_22025678_ChIP-Seq_K562_Human | 2.36400371 |
12 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.31959006 |
13 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 2.29552122 |
14 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.29259395 |
15 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.19234775 |
16 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.18400385 |
17 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.17258549 |
18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.14526787 |
19 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.13919175 |
20 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.13035810 |
21 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.12364583 |
22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.11845797 |
23 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.09117973 |
24 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.07238340 |
25 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.02689343 |
26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.01120686 |
27 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.00048975 |
28 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.94472920 |
29 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.93608728 |
30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.86634710 |
31 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.85464649 |
32 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84407996 |
33 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.79343204 |
34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.77465953 |
35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.76458959 |
36 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.69677418 |
37 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.63223939 |
38 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.62526386 |
39 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.58234239 |
40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.58172661 |
41 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.55365385 |
42 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53139342 |
43 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.52458651 |
44 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.51122158 |
45 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.49642472 |
46 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.49396834 |
47 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.48701973 |
48 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48351686 |
49 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.47680309 |
50 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.47146148 |
51 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46817539 |
52 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.46250190 |
53 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.46188197 |
54 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.44867674 |
55 | MYB_26560356_Chip-Seq_TH2_Human | 1.43648502 |
56 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.40106616 |
57 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.40054046 |
58 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.39302755 |
59 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.38822944 |
60 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.38769809 |
61 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37883385 |
62 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.37047665 |
63 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.35836624 |
64 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.35669665 |
65 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.34487516 |
66 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.33944155 |
67 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.33290430 |
68 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.30186299 |
69 | MYB_26560356_Chip-Seq_TH1_Human | 1.29170214 |
70 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.28820034 |
71 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.28331574 |
72 | MAF_26560356_Chip-Seq_TH1_Human | 1.28007438 |
73 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.26777968 |
74 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24458967 |
75 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.21240533 |
76 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21191003 |
77 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.20454150 |
78 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.19582783 |
79 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.18238413 |
80 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.16005198 |
81 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.15766400 |
82 | MAF_26560356_Chip-Seq_TH2_Human | 1.14232454 |
83 | P300_27268052_Chip-Seq_Bcells_Human | 1.12723711 |
84 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.12109299 |
85 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.11694265 |
86 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.10339762 |
87 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.10307039 |
88 | GATA3_26560356_Chip-Seq_TH2_Human | 1.09831174 |
89 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07023994 |
90 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.06912639 |
91 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.04554771 |
92 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.03350659 |
93 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.02786180 |
94 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.02466962 |
95 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.02208599 |
96 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.01835969 |
97 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.01799169 |
98 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.00742908 |
99 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.00357738 |
100 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.00198374 |
101 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.99407530 |
102 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99299634 |
103 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.98320990 |
104 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.97719892 |
105 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97346577 |
106 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97238570 |
107 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.97093891 |
108 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.96593032 |
109 | UTX_26944678_Chip-Seq_JUKART_Human | 0.96498471 |
110 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.96381319 |
111 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.95961637 |
112 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.95165873 |
113 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.94770617 |
114 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.94097550 |
115 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93834992 |
116 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.93421867 |
117 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92328546 |
118 | GATA1_19941826_ChIP-Seq_K562_Human | 0.91259855 |
119 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.90796010 |
120 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90775385 |
121 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.90414878 |
122 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90112867 |
123 | MYC_22102868_ChIP-Seq_BL_Human | 0.89949789 |
124 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.88231578 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.57670121 |
2 | MP0009785_altered_susceptibility_to | 2.92570865 |
3 | MP0003724_increased_susceptibility_to | 2.91553488 |
4 | MP0003436_decreased_susceptibility_to | 2.70737459 |
5 | * MP0002148_abnormal_hypersensitivity_rea | 2.48100972 |
6 | MP0000685_abnormal_immune_system | 2.41392495 |
7 | MP0005025_abnormal_response_to | 2.35659881 |
8 | MP0005671_abnormal_response_to | 2.26768837 |
9 | MP0003191_abnormal_cellular_cholesterol | 2.22304409 |
10 | MP0002419_abnormal_innate_immunity | 2.18686690 |
11 | MP0005000_abnormal_immune_tolerance | 2.07374581 |
12 | * MP0005464_abnormal_platelet_physiology | 2.06951867 |
13 | MP0003186_abnormal_redox_activity | 2.02332690 |
14 | MP0002139_abnormal_hepatobiliary_system | 1.94991354 |
15 | MP0004782_abnormal_surfactant_physiolog | 1.91103132 |
16 | MP0005387_immune_system_phenotype | 1.88437681 |
17 | MP0001790_abnormal_immune_system | 1.88437681 |
18 | * MP0002452_abnormal_antigen_presenting | 1.87588647 |
19 | MP0001800_abnormal_humoral_immune | 1.84097201 |
20 | MP0001853_heart_inflammation | 1.83055634 |
21 | MP0002723_abnormal_immune_serum | 1.83037330 |
22 | MP0002166_altered_tumor_susceptibility | 1.81997162 |
23 | MP0002396_abnormal_hematopoietic_system | 1.76398180 |
24 | MP0001545_abnormal_hematopoietic_system | 1.76061240 |
25 | MP0005397_hematopoietic_system_phenotyp | 1.76061240 |
26 | MP0005360_urolithiasis | 1.75795812 |
27 | MP0005058_abnormal_lysosome_morphology | 1.73692793 |
28 | MP0010155_abnormal_intestine_physiology | 1.70944851 |
29 | * MP0001819_abnormal_immune_cell | 1.69937683 |
30 | * MP0002420_abnormal_adaptive_immunity | 1.69573812 |
31 | MP0006082_CNS_inflammation | 1.65724811 |
32 | MP0005365_abnormal_bile_salt | 1.65488380 |
33 | MP0005085_abnormal_gallbladder_physiolo | 1.64413582 |
34 | MP0002006_tumorigenesis | 1.61900479 |
35 | MP0009764_decreased_sensitivity_to | 1.61546522 |
36 | MP0008875_abnormal_xenobiotic_pharmacok | 1.60826291 |
37 | MP0003172_abnormal_lysosome_physiology | 1.60592283 |
38 | MP0001845_abnormal_inflammatory_respons | 1.59648751 |
39 | MP0002138_abnormal_hepatobiliary_system | 1.58484393 |
40 | MP0002405_respiratory_system_inflammati | 1.56412818 |
41 | * MP0008469_abnormal_protein_level | 1.54105945 |
42 | MP0004947_skin_inflammation | 1.51758839 |
43 | MP0009840_abnormal_foam_cell | 1.48772813 |
44 | MP0000465_gastrointestinal_hemorrhage | 1.46969912 |
45 | MP0003763_abnormal_thymus_physiology | 1.43710924 |
46 | MP0002132_abnormal_respiratory_system | 1.42603506 |
47 | MP0009333_abnormal_splenocyte_physiolog | 1.39979457 |
48 | MP0002398_abnormal_bone_marrow | 1.38701988 |
49 | MP0006054_spinal_hemorrhage | 1.38603363 |
50 | MP0000490_abnormal_crypts_of | 1.38233455 |
51 | MP0001533_abnormal_skeleton_physiology | 1.36750873 |
52 | MP0000716_abnormal_immune_system | 1.36434818 |
53 | MP0001873_stomach_inflammation | 1.35149559 |
54 | MP0006036_abnormal_mitochondrial_physio | 1.34025796 |
55 | MP0005166_decreased_susceptibility_to | 1.33350330 |
56 | MP0000689_abnormal_spleen_morphology | 1.26327314 |
57 | MP0004808_abnormal_hematopoietic_stem | 1.23676595 |
58 | MP0002429_abnormal_blood_cell | 1.22583421 |
59 | MP0003806_abnormal_nucleotide_metabolis | 1.22299786 |
60 | MP0002722_abnormal_immune_system | 1.21350736 |
61 | MP0005083_abnormal_biliary_tract | 1.20873119 |
62 | MP0003656_abnormal_erythrocyte_physiolo | 1.20720597 |
63 | MP0005165_increased_susceptibility_to | 1.19954609 |
64 | MP0001666_abnormal_nutrient_absorption | 1.19178855 |
65 | MP0002254_reproductive_system_inflammat | 1.18913659 |
66 | MP0005451_abnormal_body_composition | 1.18465431 |
67 | MP0009379_abnormal_foot_pigmentation | 1.16872153 |
68 | MP0000858_altered_metastatic_potential | 1.15966285 |
69 | MP0000343_altered_response_to | 1.15415914 |
70 | MP0005174_abnormal_tail_pigmentation | 1.12897192 |
71 | MP0005075_abnormal_melanosome_morpholog | 1.12019338 |
72 | MP0004019_abnormal_vitamin_homeostasis | 1.11463695 |
73 | * MP0009643_abnormal_urine_homeostasis | 1.10545221 |
74 | MP0001764_abnormal_homeostasis | 1.10206607 |
75 | MP0000604_amyloidosis | 1.10124828 |
76 | MP0003866_abnormal_defecation | 1.01963681 |
77 | MP0003693_abnormal_embryo_hatching | 1.01817966 |
78 | MP0003303_peritoneal_inflammation | 0.97909181 |
79 | MP0003183_abnormal_peptide_metabolism | 0.97427008 |
80 | MP0009763_increased_sensitivity_to | 0.97013583 |
81 | MP0010329_abnormal_lipoprotein_level | 0.96807676 |
82 | MP0002877_abnormal_melanocyte_morpholog | 0.95879453 |
83 | MP0002277_abnormal_respiratory_mucosa | 0.95269953 |
84 | MP0003195_calcinosis | 0.94264713 |
85 | MP0000609_abnormal_liver_physiology | 0.92834889 |
86 | MP0003252_abnormal_bile_duct | 0.91892242 |
87 | * MP0005319_abnormal_enzyme/_coenzyme | 0.90434847 |
88 | * MP0002136_abnormal_kidney_physiology | 0.86017564 |
89 | MP0005310_abnormal_salivary_gland | 0.85618517 |
90 | MP0005408_hypopigmentation | 0.85397383 |
91 | MP0003075_altered_response_to | 0.84882258 |
92 | MP0008004_abnormal_stomach_pH | 0.83505037 |
93 | MP0005332_abnormal_amino_acid | 0.83342091 |
94 | MP0005636_abnormal_mineral_homeostasis | 0.82338384 |
95 | MP0001663_abnormal_digestive_system | 0.81640736 |
96 | MP0009278_abnormal_bone_marrow | 0.80596279 |
97 | MP0003300_gastrointestinal_ulcer | 0.79974369 |
98 | MP0000598_abnormal_liver_morphology | 0.79796308 |
99 | MP0002998_abnormal_bone_remodeling | 0.78320070 |
100 | MP0009765_abnormal_xenobiotic_induced | 0.78040320 |
101 | MP0002098_abnormal_vibrissa_morphology | 0.77302019 |
102 | MP0001958_emphysema | 0.77184479 |
103 | MP0004147_increased_porphyrin_level | 0.77158569 |
104 | MP0005084_abnormal_gallbladder_morpholo | 0.77124302 |
105 | MP0003448_altered_tumor_morphology | 0.77079920 |
106 | MP0010368_abnormal_lymphatic_system | 0.76921901 |
107 | MP0000703_abnormal_thymus_morphology | 0.76750358 |
108 | MP0004510_myositis | 0.76021374 |
109 | MP0003638_abnormal_response/metabolism_ | 0.75846015 |
110 | MP0008873_increased_physiological_sensi | 0.73710413 |
111 | MP0002019_abnormal_tumor_incidence | 0.73408177 |
112 | MP0003566_abnormal_cell_adhesion | 0.73163308 |
113 | MP0002095_abnormal_skin_pigmentation | 0.72818316 |
114 | MP0008260_abnormal_autophagy | 0.72228579 |
115 | MP0003786_premature_aging | 0.72095210 |
116 | MP0005164_abnormal_response_to | 0.71885741 |
117 | MP0001851_eye_inflammation | 0.69674601 |
118 | * MP0005584_abnormal_enzyme/coenzyme_acti | 0.69312853 |
119 | MP0001881_abnormal_mammary_gland | 0.69095454 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 4.31227097 |
2 | Recurrent bacterial skin infections (HP:0005406) | 4.20473092 |
3 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.19461004 |
4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.19461004 |
5 | Abnormality of glycolipid metabolism (HP:0010969) | 4.19461004 |
6 | Eczematoid dermatitis (HP:0000976) | 3.96284824 |
7 | Thrombocytosis (HP:0001894) | 3.76004329 |
8 | Petechiae (HP:0000967) | 3.68464457 |
9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.67250178 |
10 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.58914509 |
11 | Vacuolated lymphocytes (HP:0001922) | 3.51547332 |
12 | Abnormal number of erythroid precursors (HP:0012131) | 3.47602628 |
13 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.46850689 |
14 | Interstitial pulmonary disease (HP:0006530) | 3.28741068 |
15 | Agammaglobulinemia (HP:0004432) | 3.24794020 |
16 | Myositis (HP:0100614) | 3.15862976 |
17 | Abnormality of macrophages (HP:0004311) | 3.11722362 |
18 | Reticulocytopenia (HP:0001896) | 3.05564653 |
19 | Autoimmune thrombocytopenia (HP:0001973) | 2.93153105 |
20 | Pustule (HP:0200039) | 2.90327872 |
21 | Prolonged bleeding time (HP:0003010) | 2.86827604 |
22 | IgM deficiency (HP:0002850) | 2.85657968 |
23 | Stomatitis (HP:0010280) | 2.84504680 |
24 | Epistaxis (HP:0000421) | 2.82671997 |
25 | Recurrent skin infections (HP:0001581) | 2.70278534 |
26 | Reduced antithrombin III activity (HP:0001976) | 2.69540299 |
27 | Chronic otitis media (HP:0000389) | 2.68071605 |
28 | Joint hemorrhage (HP:0005261) | 2.62852554 |
29 | Generalized aminoaciduria (HP:0002909) | 2.60426330 |
30 | Mediastinal lymphadenopathy (HP:0100721) | 2.58397261 |
31 | Gingival bleeding (HP:0000225) | 2.55909813 |
32 | Impaired platelet aggregation (HP:0003540) | 2.55478756 |
33 | Abnormal platelet function (HP:0011869) | 2.55478756 |
34 | Loss of speech (HP:0002371) | 2.50544729 |
35 | Aplastic anemia (HP:0001915) | 2.49588777 |
36 | Abnormality of T cell physiology (HP:0011840) | 2.48322628 |
37 | Orchitis (HP:0100796) | 2.47029909 |
38 | Abnormality of B cell number (HP:0010975) | 2.45681934 |
39 | Recurrent fungal infections (HP:0002841) | 2.45493732 |
40 | Periodontitis (HP:0000704) | 2.43838596 |
41 | Systemic lupus erythematosus (HP:0002725) | 2.43373454 |
42 | Purpura (HP:0000979) | 2.43288678 |
43 | Amyloidosis (HP:0011034) | 2.39082460 |
44 | Mitochondrial inheritance (HP:0001427) | 2.38845682 |
45 | Hepatocellular necrosis (HP:0001404) | 2.38513630 |
46 | Spontaneous hematomas (HP:0007420) | 2.36363100 |
47 | Panhypogammaglobulinemia (HP:0003139) | 2.36032500 |
48 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.34351050 |
49 | Nausea (HP:0002018) | 2.33229455 |
50 | Increased intramyocellular lipid droplets (HP:0012240) | 2.32232866 |
51 | Abnormality of the nasal mucosa (HP:0000433) | 2.32212150 |
52 | Increased IgM level (HP:0003496) | 2.31371182 |
53 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.28212378 |
54 | Hepatic necrosis (HP:0002605) | 2.27908904 |
55 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.27558127 |
56 | Vasculitis (HP:0002633) | 2.25765065 |
57 | B lymphocytopenia (HP:0010976) | 2.22686557 |
58 | Hypertensive crisis (HP:0100735) | 2.22639146 |
59 | Increased muscle lipid content (HP:0009058) | 2.21684369 |
60 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.19585081 |
61 | Dicarboxylic aciduria (HP:0003215) | 2.19585081 |
62 | Microcytic anemia (HP:0001935) | 2.17851627 |
63 | Pulmonary infiltrates (HP:0002113) | 2.17562057 |
64 | Recurrent viral infections (HP:0004429) | 2.16703142 |
65 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.16566074 |
66 | Cerebral palsy (HP:0100021) | 2.15213286 |
67 | Pallor (HP:0000980) | 2.15198491 |
68 | Urticaria (HP:0001025) | 2.14558793 |
69 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.13769264 |
70 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.13769264 |
71 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.13769264 |
72 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.12581668 |
73 | Type I transferrin isoform profile (HP:0003642) | 2.12452670 |
74 | Menorrhagia (HP:0000132) | 2.12243773 |
75 | Abnormality of the prostate (HP:0008775) | 2.09770064 |
76 | Chronic obstructive pulmonary disease (HP:0006510) | 2.08969548 |
77 | Obstructive lung disease (HP:0006536) | 2.08969548 |
78 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.07357968 |
79 | Nasal polyposis (HP:0100582) | 2.06269898 |
80 | Gingivitis (HP:0000230) | 2.05760252 |
81 | Renal Fanconi syndrome (HP:0001994) | 2.05478606 |
82 | Acute necrotizing encephalopathy (HP:0006965) | 2.05341600 |
83 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.04953402 |
84 | Cellulitis (HP:0100658) | 2.04024432 |
85 | Prolonged partial thromboplastin time (HP:0003645) | 2.03703746 |
86 | Increased CSF lactate (HP:0002490) | 2.02718656 |
87 | Mucopolysacchariduria (HP:0008155) | 2.01337189 |
88 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.01337189 |
89 | Abnormality of the intrinsic pathway (HP:0010989) | 2.00181939 |
90 | Increased cerebral lipofuscin (HP:0011813) | 1.99828757 |
91 | Meningitis (HP:0001287) | 1.99342656 |
92 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.99059505 |
93 | Recurrent bronchitis (HP:0002837) | 1.98046856 |
94 | Macrocytic anemia (HP:0001972) | 1.97508464 |
95 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.97445728 |
96 | Progressive neurologic deterioration (HP:0002344) | 1.96822654 |
97 | Increased IgE level (HP:0003212) | 1.93799460 |
98 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.93716553 |
99 | Prostate neoplasm (HP:0100787) | 1.92425571 |
100 | Basal ganglia calcification (HP:0002135) | 1.92374019 |
101 | Chronic diarrhea (HP:0002028) | 1.91712181 |
102 | Poor head control (HP:0002421) | 1.90487684 |
103 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.90006613 |
104 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.90006613 |
105 | Prolonged neonatal jaundice (HP:0006579) | 1.89908184 |
106 | Disinhibition (HP:0000734) | 1.89618904 |
107 | Retrobulbar optic neuritis (HP:0100654) | 1.88543936 |
108 | Optic neuritis (HP:0100653) | 1.88543936 |
109 | Abnormality of T cells (HP:0002843) | 1.87822208 |
110 | Pulmonary fibrosis (HP:0002206) | 1.87212383 |
111 | Proximal tubulopathy (HP:0000114) | 1.86746175 |
112 | Abnormality of the common coagulation pathway (HP:0010990) | 1.85517394 |
113 | Increased serum ferritin (HP:0003281) | 1.84693027 |
114 | Hypergammaglobulinemia (HP:0010702) | 1.84185937 |
115 | Complement deficiency (HP:0004431) | 1.82108781 |
116 | Gastrointestinal inflammation (HP:0004386) | 1.81887424 |
117 | Hepatosplenomegaly (HP:0001433) | 1.81265372 |
118 | Beaking of vertebral bodies (HP:0004568) | 1.78775410 |
119 | Autoimmune hemolytic anemia (HP:0001890) | 1.78566220 |
120 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.78549972 |
121 | Neutropenia (HP:0001875) | 1.77875604 |
122 | Abnormality of iron homeostasis (HP:0011031) | 1.76073113 |
123 | Skin ulcer (HP:0200042) | 1.75351875 |
124 | Thrombophlebitis (HP:0004418) | 1.75028017 |
125 | Recurrent cutaneous fungal infections (HP:0011370) | 1.74341528 |
126 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.74341528 |
127 | Glomerulonephritis (HP:0000099) | 1.72995514 |
128 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.72852755 |
129 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.72852755 |
130 | Abnormal protein glycosylation (HP:0012346) | 1.72852755 |
131 | Abnormal glycosylation (HP:0012345) | 1.72852755 |
132 | Arterial thrombosis (HP:0004420) | 1.70671078 |
133 | Hypoglycemic coma (HP:0001325) | 1.70466001 |
134 | Granulocytopenia (HP:0001913) | 1.70199631 |
135 | Dysostosis multiplex (HP:0000943) | 1.68824087 |
136 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.68536709 |
137 | Skin rash (HP:0000988) | 1.68383506 |
138 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.68236609 |
139 | Encephalitis (HP:0002383) | 1.68197621 |
140 | Hemoptysis (HP:0002105) | 1.67847502 |
141 | Inflammation of the large intestine (HP:0002037) | 1.67790711 |
142 | Erythema (HP:0010783) | 1.67692296 |
143 | Renal cortical cysts (HP:0000803) | 1.67587842 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TESK2 | 3.64582956 |
2 | VRK2 | 3.55347867 |
3 | NME2 | 3.01910411 |
4 | MAP4K1 | 2.64421787 |
5 | ERN1 | 2.49910491 |
6 | MAP3K14 | 2.48390483 |
7 | TBK1 | 2.42467284 |
8 | IRAK3 | 2.31514370 |
9 | PIM2 | 2.29075783 |
10 | KIT | 2.18325298 |
11 | TYK2 | 2.17583749 |
12 | IKBKE | 2.12625791 |
13 | BLK | 2.11618516 |
14 | IRAK4 | 2.11558730 |
15 | TXK | 2.09591105 |
16 | SCYL2 | 2.05343491 |
17 | TEC | 1.96206320 |
18 | TGFBR2 | 1.91303172 |
19 | ZAP70 | 1.89828036 |
20 | MAP2K3 | 1.86849229 |
21 | JAK3 | 1.86233574 |
22 | IKBKB | 1.83577330 |
23 | BCKDK | 1.82666576 |
24 | BTK | 1.82106895 |
25 | FES | 1.67664306 |
26 | MAP3K3 | 1.61730357 |
27 | TIE1 | 1.60975165 |
28 | TGFBR1 | 1.57114671 |
29 | KDR | 1.56010100 |
30 | GRK7 | 1.52678580 |
31 | NEK9 | 1.52523799 |
32 | RPS6KA4 | 1.51932644 |
33 | STK16 | 1.45578577 |
34 | MST4 | 1.42346662 |
35 | TAOK3 | 1.41538859 |
36 | RIPK4 | 1.40732604 |
37 | BMPR2 | 1.40520540 |
38 | FLT3 | 1.39052486 |
39 | LRRK2 | 1.34219765 |
40 | GRK6 | 1.32013488 |
41 | MST1R | 1.25982934 |
42 | MUSK | 1.24706168 |
43 | SYK | 1.19697512 |
44 | DAPK1 | 1.19362280 |
45 | PIM1 | 1.19152953 |
46 | MAP3K12 | 1.16042531 |
47 | MATK | 1.13477500 |
48 | ACVR1B | 1.13215610 |
49 | RPS6KB2 | 1.12701943 |
50 | TNK2 | 1.11724750 |
51 | MYLK | 1.10037453 |
52 | FGFR4 | 1.08696222 |
53 | ARAF | 1.08472813 |
54 | PIK3CG | 1.04641220 |
55 | CHUK | 1.04237489 |
56 | LYN | 1.01255378 |
57 | MAP3K11 | 1.00860584 |
58 | STK10 | 0.99781957 |
59 | PBK | 0.98383910 |
60 | CSF1R | 0.97211645 |
61 | NUAK1 | 0.94296300 |
62 | VRK1 | 0.90013409 |
63 | EIF2AK3 | 0.89126081 |
64 | JAK1 | 0.88310274 |
65 | TRPM7 | 0.85930810 |
66 | ABL2 | 0.85863285 |
67 | MAPKAPK3 | 0.83645156 |
68 | NLK | 0.83303517 |
69 | PRKG2 | 0.80825623 |
70 | PAK4 | 0.79799957 |
71 | EIF2AK1 | 0.78018924 |
72 | EIF2AK2 | 0.75998545 |
73 | JAK2 | 0.75513492 |
74 | DYRK3 | 0.75014194 |
75 | ZAK | 0.74119390 |
76 | LCK | 0.72804296 |
77 | TLK1 | 0.72320465 |
78 | CSK | 0.72027934 |
79 | STK4 | 0.70100295 |
80 | MAP2K6 | 0.68844849 |
81 | PRKCQ | 0.66772791 |
82 | HCK | 0.62345858 |
83 | ADRBK2 | 0.61842894 |
84 | WEE1 | 0.59433482 |
85 | LIMK1 | 0.58335699 |
86 | MAP3K1 | 0.57986398 |
87 | STK24 | 0.57221820 |
88 | RPS6KA6 | 0.56985503 |
89 | GRK1 | 0.56588407 |
90 | CDK6 | 0.54610337 |
91 | PKN2 | 0.54609212 |
92 | PRKCD | 0.52666913 |
93 | ILK | 0.52240476 |
94 | PDK2 | 0.51750225 |
95 | MAP4K2 | 0.50062085 |
96 | MAPKAPK2 | 0.49830844 |
97 | EPHA3 | 0.48235268 |
98 | PLK4 | 0.47695632 |
99 | EEF2K | 0.47447188 |
100 | FGFR3 | 0.47045701 |
101 | EPHA2 | 0.46572525 |
102 | MAPK11 | 0.46564031 |
103 | CDK8 | 0.46480195 |
104 | RPS6KL1 | 0.46445559 |
105 | RPS6KC1 | 0.46445559 |
106 | CCNB1 | 0.44061461 |
107 | MAPKAPK5 | 0.44009402 |
108 | AURKB | 0.42711700 |
109 | RPS6KA5 | 0.41739086 |
110 | TAOK2 | 0.41621378 |
111 | MAP2K2 | 0.41590152 |
112 | ITK | 0.40735283 |
113 | EPHB1 | 0.40323623 |
114 | MOS | 0.39782031 |
115 | HIPK2 | 0.39773251 |
116 | TESK1 | 0.39541156 |
117 | PASK | 0.39080641 |
118 | FGR | 0.38782363 |
119 | ABL1 | 0.38656069 |
120 | BUB1 | 0.38462809 |
121 | CDK7 | 0.38216602 |
122 | YES1 | 0.38191745 |
123 | GRK5 | 0.38000349 |
124 | MAP3K5 | 0.35984276 |
125 | SMG1 | 0.33948846 |
126 | BMX | 0.33758924 |
127 | DAPK3 | 0.33419298 |
128 | IGF1R | 0.32522485 |
129 | NME1 | 0.30736879 |
130 | MAP3K13 | 0.30391370 |
131 | TAOK1 | 0.28863443 |
132 | PDK1 | 0.28092874 |
133 | MAPK15 | 0.27628882 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome_Homo sapiens_hsa03010 | 3.24211190 |
2 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.62555844 |
3 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.48458106 |
4 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.22858349 |
5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.01304790 |
6 | Leishmaniasis_Homo sapiens_hsa05140 | 1.95025415 |
7 | Proteasome_Homo sapiens_hsa03050 | 1.81274012 |
8 | Other glycan degradation_Homo sapiens_hsa00511 | 1.71336222 |
9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.71313043 |
10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.70160323 |
11 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.69965666 |
12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.67412992 |
13 | Legionellosis_Homo sapiens_hsa05134 | 1.65824374 |
14 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.63122493 |
15 | DNA replication_Homo sapiens_hsa03030 | 1.61536266 |
16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.59318142 |
17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.58599030 |
18 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.58045622 |
19 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.53837390 |
20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.52829703 |
21 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.48734749 |
22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.46771353 |
23 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.45845965 |
24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.45459368 |
25 | Protein export_Homo sapiens_hsa03060 | 1.44782319 |
26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.44774052 |
27 | Pertussis_Homo sapiens_hsa05133 | 1.38047761 |
28 | Measles_Homo sapiens_hsa05162 | 1.36723330 |
29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.35440932 |
30 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.34672050 |
31 | Allograft rejection_Homo sapiens_hsa05330 | 1.34661049 |
32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.34600053 |
33 | Malaria_Homo sapiens_hsa05144 | 1.30207889 |
34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.29673422 |
35 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.28264482 |
36 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.26808781 |
37 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.26775463 |
38 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.26273302 |
39 | Sulfur relay system_Homo sapiens_hsa04122 | 1.25266532 |
40 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.23636237 |
41 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.22654774 |
42 | Parkinsons disease_Homo sapiens_hsa05012 | 1.22075210 |
43 | Peroxisome_Homo sapiens_hsa04146 | 1.17975728 |
44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.17235442 |
45 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.13785164 |
46 | Asthma_Homo sapiens_hsa05310 | 1.12874550 |
47 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.10567515 |
48 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.10131128 |
49 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.07291930 |
50 | Base excision repair_Homo sapiens_hsa03410 | 1.05778637 |
51 | Lysosome_Homo sapiens_hsa04142 | 1.04353765 |
52 | Histidine metabolism_Homo sapiens_hsa00340 | 1.02944230 |
53 | Influenza A_Homo sapiens_hsa05164 | 1.02463954 |
54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.02095661 |
55 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.01893297 |
56 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.01652733 |
57 | RNA polymerase_Homo sapiens_hsa03020 | 0.99269295 |
58 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.98942934 |
59 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.98056722 |
60 | Retinol metabolism_Homo sapiens_hsa00830 | 0.97807282 |
61 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.94807361 |
62 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.94251576 |
63 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.94090620 |
64 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.92891522 |
65 | Galactose metabolism_Homo sapiens_hsa00052 | 0.89056342 |
66 | Apoptosis_Homo sapiens_hsa04210 | 0.88590356 |
67 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.86471041 |
68 | Tuberculosis_Homo sapiens_hsa05152 | 0.86178100 |
69 | Homologous recombination_Homo sapiens_hsa03440 | 0.84918435 |
70 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.83965287 |
71 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.81486519 |
72 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.81200103 |
73 | Mismatch repair_Homo sapiens_hsa03430 | 0.79959001 |
74 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.79618407 |
75 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.78041669 |
76 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.77466669 |
77 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.76344795 |
78 | Huntingtons disease_Homo sapiens_hsa05016 | 0.75859972 |
79 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.74928240 |
80 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.74911346 |
81 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.74794059 |
82 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.74558905 |
83 | * SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.74185924 |
84 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.73144710 |
85 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.72855687 |
86 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.72574460 |
87 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.72237877 |
88 | Salmonella infection_Homo sapiens_hsa05132 | 0.70449799 |
89 | Alzheimers disease_Homo sapiens_hsa05010 | 0.70404844 |
90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70162896 |
91 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.70110319 |
92 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.68300707 |
93 | Shigellosis_Homo sapiens_hsa05131 | 0.66915558 |
94 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.66806709 |
95 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.62792447 |
96 | Hepatitis C_Homo sapiens_hsa05160 | 0.61129599 |
97 | ABC transporters_Homo sapiens_hsa02010 | 0.60750380 |
98 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60737468 |
99 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.57573759 |
100 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.56676201 |
101 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.55747091 |
102 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.55379032 |
103 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.54530846 |
104 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.52949765 |
105 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.51552352 |
106 | Phagosome_Homo sapiens_hsa04145 | 0.51540770 |
107 | Hepatitis B_Homo sapiens_hsa05161 | 0.50769355 |
108 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.50456502 |
109 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.49887897 |
110 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.49717061 |
111 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.49650776 |
112 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.49423320 |
113 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.48647194 |
114 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.47400299 |
115 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.46892920 |
116 | Mineral absorption_Homo sapiens_hsa04978 | 0.46753359 |
117 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.46705399 |
118 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.44588418 |
119 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43437205 |
120 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.42991311 |
121 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.41637238 |
122 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.38111592 |
123 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34112514 |
124 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.33886593 |